Drawing based on the label description. No photo yet.
“Yellow, ovaloid shaped, biconvex, film -coated tablet debossed with "475" on one side and breakline on the other side”
475 pill
Pill with imprint 475 is yellow, oval, 20 mm and has been identified as Imatinib Mesylate 400 mg. It is used for lymphoid leukemia, myeloid leukemia and dermatofibrosarcoma. It is supplied by Bluepoint Laboratories.
Imatinib Mesylate 400 mg
- Imprint
- 475
- Strength
- 400 mg
- Used for
- Lymphoid leukemia, myeloid leukemia and dermatofibrosarcoma
- Color
- Yellow
- Shape
- Oval
- Size
- 20 mm
- Score
- Breaks into 2 pieces
- Form
- Tablet, film coated
- Manufacturer
- Bluepoint Laboratories
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 68001-491, 68001-491-04, 47335-475, 47335-475-83, 47335-475-88, 47335-475-13, 47335-475-64
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Imatinib used for?
Imatinib is used for lymphoid leukemia, myeloid leukemia and dermatofibrosarcoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Newly Diagnosed Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML)
Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Ph+ CML in Blast Crisis (BC), Accelerated Phase (AP) or Chronic Phase (CP) After Interferon-alpha (IFN) Therapy
Patients with Philadelphia chromosome positive chronic myeloid leukemia in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.
Adult Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Pediatric Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
Pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy.
Myelodysplastic/Myeloproliferative Diseases (MDS/MPD)
Adult patients with myelodysplastic/myeloproliferative diseases associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements.
Aggressive Systemic Mastocytosis (ASM)
Adult patients with aggressive systemic mastocytosis without the D816V c-Kit mutation or with c-Kit mutational status unknown.
Hypereosinophilic Syndrome (HES) and/or Chronic Eosinophilic Leukemia (CEL)
Adult patients with hypereosinophilic syndrome and/or chronic eosinophilic leukemia who have the FIP1L1-PDGFRα fusion kinase (mutational analysis or fluorescence in situ hybridization [FISH] demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRα fusion kinase negative or unknown.
Dermatofibrosarcoma Protuberans (DFSP)
Adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans.
Kit+ Gastrointestinal Stromal Tumors (GIST)
Patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors.
Adjuvant Treatment of GIST
Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.
From the FDA-approved label on DailyMed (published Oct 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows 475 and the other side has only a score line.
- It is yellow, oval, 20 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Imatinib Mesylate
Inactive: Microcrystalline Cellulose, Mannitol, Copovidone K25-31, Crospovidone (120 .mu.m), Magnesium Stearate, Hypromellose, Unspecified, Ferric Oxide Yellow, Polyethylene Glycol, Unspecified, Titanium Dioxide, Fd&c Yellow No. 6, Ferric Oxide Red
Also distributed by
Sun Pharmaceutical Industries, Inc.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G 13 and 9
Oxcarbazepine 600 mg
Yellow, oval, 19 mm
Used for focal seizures
-
G
Colestipol Hydrochloride 1 g
Yellow, oval, 21 mm
Used for high cholesterol and high triglycerides
-
656 P
Zileuton 600 mg
Yellow, oval, 20 mm
Used for asthma
-
537
Potassium Citrate 10 mEq
Yellow, oval, 19 mm
Used for low potassium and renal tubular acidosis
-
G 13 9
Oxcarbazepine 600 mg
Yellow, oval, 19 mm
Used for focal seizures
- DM4 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 21 mm Used for type 2 diabetes and heart failure
Other Imatinib pills
-
IMA 100 APO
Imatinib Mesylate 100 mg
Orange, round, 9 mm
Used for lymphoid leukemia and myeloid leukemia
- S 1 Imatinib Mesylate 100 mg Yellow, round, 7 mm Used for lymphoid leukemia and myeloid leukemia
- 51 Imatinib Mesylate 100 mg Brown, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- 472 Imatinib Mesylate 100 mg Yellow, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- 1 scoreline Imatinib 100 mg Yellow, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- M I 100 Imatinib 100 mg Brown, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- H 7 Imatinib Mesylate 100 mg White, round, 9 mm Used for lymphoid leukemia and myeloid leukemia
- CE 138 Imatinib Mesylate 100 mg Orange, round, 7 mm Used for lymphoid leukemia and myeloid leukemia